- Home
- CRMT vs ATXS Comparison
CRMT vs ATXS Comparison
Compare CRMT & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMT
- ATXS
- Stock Information
- Founded
- CRMT 1981
- ATXS 2008
- Country
- CRMT United States
- ATXS United States
- Employees
- CRMT N/A
- ATXS N/A
- Industry
- CRMT Other Specialty Stores
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- CRMT Consumer Discretionary
- ATXS Health Care
- Exchange
- CRMT Nasdaq
- ATXS Nasdaq
- Market Cap
- CRMT 389.6M
- ATXS 401.2M
- IPO Year
- CRMT N/A
- ATXS 2015
- Fundamental
- Price
- CRMT $57.87
- ATXS $6.32
- Analyst Decision
- CRMT Hold
- ATXS Strong Buy
- Analyst Count
- CRMT 1
- ATXS 7
- Target Price
- CRMT $50.00
- ATXS $32.43
- AVG Volume (30 Days)
- CRMT 98.2K
- ATXS 341.9K
- Earning Date
- CRMT 09-03-2025
- ATXS 08-11-2025
- Dividend Yield
- CRMT N/A
- ATXS N/A
- EPS Growth
- CRMT N/A
- ATXS N/A
- EPS
- CRMT 2.33
- ATXS N/A
- Revenue
- CRMT $1,390,932,000.00
- ATXS N/A
- Revenue This Year
- CRMT $1.95
- ATXS N/A
- Revenue Next Year
- CRMT $10.30
- ATXS N/A
- P/E Ratio
- CRMT $24.81
- ATXS N/A
- Revenue Growth
- CRMT 0.14
- ATXS N/A
- 52 Week Low
- CRMT $36.40
- ATXS $3.56
- 52 Week High
- CRMT $72.26
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- CRMT 62.02
- ATXS 63.95
- Support Level
- CRMT $58.67
- ATXS $6.27
- Resistance Level
- CRMT $62.53
- ATXS $5.79
- Average True Range (ATR)
- CRMT 2.08
- ATXS 0.38
- MACD
- CRMT 0.11
- ATXS 0.06
- Stochastic Oscillator
- CRMT 74.31
- ATXS 81.40
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.